Progression-free survival and local control after SABR for up to 5 oligometastases: an analysis from the population-based phase 2 SABR-5 trial
S Baker, W Jiang, B Mou, CR Lund, M Liu… - International Journal of …, 2022 - Elsevier
Purpose Despite increasing utilization of SABR for oligometastatic cancer, prospective
outcomes are lacking. The purpose of this study was to determine progression-free survival
(PFS), local control (LC), and prognostic factors from the population-based phase 2 SABR-5
trial. Methods and Materials The SABR-5 trial was a single-arm phase 2 study with the
primary endpoint of toxicity, conducted at the 6 regional cancer centers across British
Columbia (BC), Canada, during which time SABR for oligometastases was only offered on …
outcomes are lacking. The purpose of this study was to determine progression-free survival
(PFS), local control (LC), and prognostic factors from the population-based phase 2 SABR-5
trial. Methods and Materials The SABR-5 trial was a single-arm phase 2 study with the
primary endpoint of toxicity, conducted at the 6 regional cancer centers across British
Columbia (BC), Canada, during which time SABR for oligometastases was only offered on …